PMID- 27536984 OWN - NLM STAT- MEDLINE DCOM- 20171220 LR - 20180522 IS - 1473-5571 (Electronic) IS - 0269-9370 (Linking) VI - 30 IP - 16 DP - 2016 Oct 23 TI - Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers. PG - 2561-2563 AB - The immune reconstitution inflammatory syndrome (IRIS) remains a concern in severely immunosuppressed HIV-infected patients after starting antiretroviral therapy. We present an HIV-infected transgender woman with subcutaneous silicone fillers, who simultaneously developed tuberculosis-associated and silicone-related IRIS. We propose a possible connection between IRIS and the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). FAU - Alvarez, Hortensia AU - Alvarez H AD - aInfectious Diseases Unit, Internal Medicine Department, University Hospital of Ferrol, A Coruna bDermatology Department, University Hospital of Ferrol, A Coruna cHospital Pharmacy, University Hospital of Ferrol, A Coruna dInfectious Diseases and 'Lluita contra la SIDA' Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona eUniversitat Autonoma de Barcelona, Barcelona, Spain. FAU - Marino, Ana AU - Marino A FAU - Garcia-Rodriguez, Jose F AU - Garcia-Rodriguez JF FAU - Vilas-Sueiro, Alejandro AU - Vilas-Sueiro A FAU - Valcarce, Nieves AU - Valcarce N FAU - Llibre, Josep M AU - Llibre JM LA - eng PT - Case Reports PT - Journal Article PL - England TA - AIDS JT - AIDS (London, England) JID - 8710219 RN - 0 (Dermal Fillers) RN - 0 (Silicones) SB - IM MH - Adult MH - Asia MH - Dermal Fillers/*adverse effects MH - HIV Infections/*complications/*drug therapy MH - Humans MH - Immune Reconstitution Inflammatory Syndrome MH - Silicones/*adverse effects MH - Transgender Persons MH - Tuberculosis/pathology EDAT- 2016/10/19 06:00 MHDA- 2017/12/21 06:00 CRDT- 2016/08/19 06:00 PHST- 2016/10/19 06:00 [pubmed] PHST- 2017/12/21 06:00 [medline] PHST- 2016/08/19 06:00 [entrez] AID - 10.1097/QAD.0000000000001239 [doi] PST - ppublish SO - AIDS. 2016 Oct 23;30(16):2561-2563. doi: 10.1097/QAD.0000000000001239.